SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-22-006197
Filing Date
2022-03-16
Accepted
2022-03-16 16:06:15
Documents
57
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q organicell_10q.htm   iXBRL 10-Q 694363
2 EXHIBIT 31.1 organicell_ex31-1.htm EX-31.1 12628
3 EXHIBIT 31.2 organicell_ex31-2.htm EX-31.2 12333
4 EXHIBIT 32.1 organicell_ex32-1.htm EX-32.1 4808
5 EXHIBIT 32.2 organicell_ex32-2.htm EX-32.2 4916
  Complete submission text file 0001829126-22-006197.txt   3969199

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bpsr-20220131.xsd EX-101.SCH 36026
7 XBRL CALCULATION FILE bpsr-20220131_cal.xml EX-101.CAL 42515
8 XBRL DEFINITION FILE bpsr-20220131_def.xml EX-101.DEF 127807
9 XBRL LABEL FILE bpsr-20220131_lab.xml EX-101.LAB 271773
10 XBRL PRESENTATION FILE bpsr-20220131_pre.xml EX-101.PRE 223477
51 EXTRACTED XBRL INSTANCE DOCUMENT organicell_10q_htm.xml XML 525107
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 22744914
SIC: 3790 Miscellaneous Transportation Equipment